Access here alternative investment news about Beacon Biosignals Raises $27M Series A Led By General Catalyst To Scale Its Eeg Neurobiomarker Discovery Platform
Venture Capital

Beacon Biosignals Raises $27M Series A Led By General Catalyst To Scale Its Eeg Neurobiomarker Discovery Platform

by prnewswire.com posted 2weeks ago 177 views
BOSTON, Nov. 8, 2021 /PRNewswire/ -- Beacon Biosignals, a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain, has announced an oversubscribed $27M Series A financing led by General...